467 related articles for article (PubMed ID: 34258870)
1. Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.
Wang X; Brown NK; Wang B; Shariati K; Wang K; Fuchs S; Melero-Martin JM; Ma M
Adv Sci (Weinh); 2021 Sep; 8(17):e2003708. PubMed ID: 34258870
[TBL] [Abstract][Full Text] [Related]
2. Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation.
Ho BX; Teo AKK; Ng NHJ
Front Immunol; 2024; 15():1375177. PubMed ID: 38650946
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants.
Li Y; Frei AW; Labrada IM; Rong Y; Liang JP; Samojlik MM; Sun C; Barash S; Keselowsky BG; Bayer AL; Stabler CL
Front Immunol; 2021; 12():653088. PubMed ID: 34122410
[TBL] [Abstract][Full Text] [Related]
4. Strategies for durable β cell replacement in type 1 diabetes.
Brusko TM; Russ HA; Stabler CL
Science; 2021 Jul; 373(6554):516-522. PubMed ID: 34326233
[TBL] [Abstract][Full Text] [Related]
5. Bio-synthetic materials for immunomodulation of islet transplants.
Foster GA; García AJ
Adv Drug Deliv Rev; 2017 May; 114():266-271. PubMed ID: 28532691
[TBL] [Abstract][Full Text] [Related]
6. Rotational culture and integration with amniotic stem cells reduce porcine islet immunoreactivity in vitro and slow xeno-rejection in a murine model of islet transplantation.
Zafar A; Lee J; Yesmin S; Paget MB; Bailey CJ; Murray HE; Downing R
Xenotransplantation; 2019 Jul; 26(4):e12508. PubMed ID: 30963627
[TBL] [Abstract][Full Text] [Related]
7. Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery.
Lansberry TR; Stabler CL
Adv Drug Deliv Rev; 2024 Mar; 206():115179. PubMed ID: 38286164
[TBL] [Abstract][Full Text] [Related]
8. Stem cell-based immunomodulation in type 1 diabetes: beyond the regenerative approach.
Longoni B; Mosca F
Curr Pharm Des; 2011; 17(29):3229-42. PubMed ID: 21864271
[TBL] [Abstract][Full Text] [Related]
9. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
[TBL] [Abstract][Full Text] [Related]
10. [Treatment diabetes by transplantation of insulin secreting cells. Part II--prevention of rejection of the transplanted cells].
Pokrywczyńska M; Drewa T; Włodarczyk Z; Dufrane D
Pol Merkur Lekarski; 2006 May; 20(119):619-21. PubMed ID: 16875176
[TBL] [Abstract][Full Text] [Related]
11. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge.
Caldara R; Tomajer V; Monti P; Sordi V; Citro A; Chimienti R; Gremizzi C; Catarinella D; Tentori S; Paloschi V; Melzi R; Mercalli A; Nano R; Magistretti P; Partelli S; Piemonti L
Front Immunol; 2023; 14():1323439. PubMed ID: 38077372
[TBL] [Abstract][Full Text] [Related]
12. Biological and biomaterial approaches for improved islet transplantation.
Narang AS; Mahato RI
Pharmacol Rev; 2006 Jun; 58(2):194-243. PubMed ID: 16714486
[TBL] [Abstract][Full Text] [Related]
13. [Xenotransplantation of islets of Langerhans: a possible therapy for diabetes mellitus?].
Igaz P
Wien Med Wochenschr; 2001; 151(13-14):291-4. PubMed ID: 11582992
[TBL] [Abstract][Full Text] [Related]
14. Islet Encapsulation: Physiological Possibilities and Limitations.
Korsgren O
Diabetes; 2017 Jul; 66(7):1748-1754. PubMed ID: 28637827
[TBL] [Abstract][Full Text] [Related]
15. Islet cell transplantation.
Vaithilingam V; Sundaram G; Tuch BE
Curr Opin Organ Transplant; 2008 Dec; 13(6):633-8. PubMed ID: 19060555
[TBL] [Abstract][Full Text] [Related]
16. Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity.
Qureshi KM; Lee J; Paget MB; Bailey CJ; Curnow SJ; Murray HE; Downing R
Clin Transplant; 2015 Jan; 29(1):90-8. PubMed ID: 25382449
[TBL] [Abstract][Full Text] [Related]
17. Alginate-microencapsulation of human stem cell-derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression.
Alagpulinsa DA; Cao JJL; Driscoll RK; Sîrbulescu RF; Penson MFE; Sremac M; Engquist EN; Brauns TA; Markmann JF; Melton DA; Poznansky MC
Am J Transplant; 2019 Jul; 19(7):1930-1940. PubMed ID: 30748094
[TBL] [Abstract][Full Text] [Related]
18. Therapies for Type 1 Diabetes: Is a Cure Possible?
Chuzho N; Mishra N; Tandon N; Kumar N
Curr Diabetes Rev; 2023; 19(7):e021222211565. PubMed ID: 36476434
[TBL] [Abstract][Full Text] [Related]
19. Islet cell transplantation for insulin-dependent diabetes.
Lacy PE
Hosp Pract (1995); 1995 Jun; 30(6):41-5. PubMed ID: 7782398
[TBL] [Abstract][Full Text] [Related]
20. Islet and stem cell encapsulation for clinical transplantation.
Krishnan R; Alexander M; Robles L; Foster CE; Lakey JR
Rev Diabet Stud; 2014; 11(1):84-101. PubMed ID: 25148368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
